The same ASX Aware Query states
Because SaaS businesses like Pointerra have a no lock-in/commitment commercial model (ie thecustomer can cancel at any time), ACV/ARR for SaaS businesses is expressed as the annualised totalof all customers (regardless of their payment cycle/frequency) at any point in time.If a customer stops paying or cancels their account then their contribution to ACV isremoved. Similarly, if a customer grows/reduces their spend there is a similar upward impact onACV.
There's a mismatch in how these are treated. Consider a new contract, which immediately contributes to ACV (we have seen announcements to that effect in the past). Yet a new customer is very likely not paying anything yet as they are still figuring out how to get their data into the platform.
I have long stated that in my experience, these SaaS "contracts" and "commitments" are merely intentional statements and are not binding. SaaS is a "pay-as-you-go" system, and if you stop "going" you stop paying. ACV is thus merely a guesstimate of where we are at any point in time, and it seems not a great guesstimate at that.
I agree 100% that this should be called ARR, not ACV. The terminology is very misleading. I further expect that we'll move away from this metric to instead reporting invoiced revenue.
- Forums
- ASX - By Stock
- ACV & Revenue / cash received mismatch
The same ASX Aware Query statesBecause SaaS businesses like...
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 3DP (ASX) to my watchlist
|
|||||
Last
7.4¢ |
Change
0.011(17.5%) |
Mkt cap ! $59.57M |
Open | High | Low | Value | Volume |
6.9¢ | 8.1¢ | 6.5¢ | $787.7K | 10.79M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 181246 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.073 |
4 | 127892 | 0.070 |
3 | 322478 | 0.069 |
3 | 281800 | 0.068 |
2 | 115000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 181246 | 2 |
0.075 | 58907 | 2 |
0.077 | 25000 | 1 |
0.078 | 25001 | 1 |
0.079 | 160746 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
3DP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online